Wang 2016b.
Methods | Randomised study which appears to have 3 intervention arms. |
Participants | Preterm infants < 37 weeks' gestation |
Interventions | 156 infants randomised to either OS‐LE or MS‐LE or S‐LE. |
Outcomes | Fatty acid profile, anthropometry and several clinical parameters |
Notes | Published in Clinical Nutrition and appeared to have 2 out of 3 arms common with an earlier report of a randomised study (Wang 2016) in Journal of Parenteral and Enteral Nutrition, which was included in the previous version of this review. Several baseline participant characteristics were common between the 2 reports and there were some data irregularities which were brought to the notice of the editors of the journals. At the time of writing this review, we are awaiting clarifications and some changes expected to the study reports as per the editors of the 2 journals. We included the data from the earlier report of the study published in Journal of Parenteral and Enteral Nutrition for the consistently reported data between the 2 study reports (Wang 2016). |
ALT: alanine aminotransferase; LCT: long‐chain triglyceride; LE: lipid emulsion; MCT: medium‐chain triglyceride; MOFS‐LE: medium‐chain triglyceride‐olive‐fish‐soybean oil lipid emulsion; MS‐LE: medium‐chain triglyceride‐soybean oil lipid emulsion; NICU: neonatal intensive care unit; OS‐LE: olive oil‐soybean oil‐based lipid emulsion; PN: parenteral nutrition; PTT: prothrombin time; PUFA: polyunsaturated fatty acid; RCT: randomised controlled trial; S‐LE: soybean oil‐based lipid emulsion; TPNAC: total parenteral nutrition‐associated cholestasis.